Stockreport

Nucala (mepolizumab) Gains FDA Approval for Two New Self-Administration Options

GSK plc American Depositary Shares (Each representing two Ordinary Shares)  (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors
PDF First anti-IL5 biologic to give healthcare professionals choice of how and where their patients receive treatment LONDON--(BUSINESS WIRE)-- Gl [Read more]